The Lancet Gastroenterology & Hepatology
Fecha de publicación: 3 June 2019
Autores: Marjorie Argollo, MD., Daniela Gilardi, PharmaD., Carina Peyrin-Biroulet, MD., Jean-Francois Chabot, PhD., Laurent Peyrin-Biroulet, PhD., Prof Silvio Danese, PhD.
Background: Inflammatory bowel disease (IBD) is a chronic systemic inflammatory condition. Previously, the focus has been on extraintestinal manifestations of IBD, including arthritis, psoriasis, and uveitis. Although comorbidities have long been the subject of intensive research in other chronic inflammatory diseases such as rheumatoid arthritis, the concept of comorbidities is only beginning to emerge in IBD.Leer más